Sarah A. Pridgen

Sarah A. Pridgen

Auto-generated profile, based on publicly available information

Sarah A. Pridgen

Department of Psychiatry and Behavioral Sciences, Rush University Medical Center, Chicago, IL, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in Psychological Trauma: Theory, Research, Practice, and Policy
Verified
Journal Article
Closed access
PHPhilip Held
Philip Held
DSDale L. Smith
Dale L. Smith
SPSarah Pridgen
Sarah Pridgen
JCJennifer A. Coleman
Jennifer A. Coleman
BKBrian J. Klassen
Brian J. Klassen
Although there is mounting evidence that massed treatment for PTSD is both feasible and effective, many questions remain about the optimal length of intensive treatment programs (ITPs), as well as the role of adjunctive services, such as psychoeducation, mindfulness, and yoga. Our setting recently transitioned from a three-week ITP to a two-week program. Adjunctive services were reduced, but the amount of individual CPT between programs remained similar. The present study examined the effectiveness of a two-week ITP based on twice daily individual CPT sessions and evaluated the program's noninferiority to an established three-week ITP using a Bayesian analytical approach. Bayesian linear mixed regression models were used to explore PTSD and depression changes over time, as well as predictors of change. Noninferiority of the two-week ITP to a three-week ITP was also established using a Bayes factor approach. Results indicate that program participants change meaningfully in both PTSD and depression severity over the course of treatment, and that changes in posttraumatic cognitions predict subsequent changes in these outcomes. Further, the two-week ITP can be considered noninferior to the three-week ITP in both clinical outcomes and overall satisfaction. In the context of intensive PTSD treatment, the content of the ITP appears to matter more than its overall length. Shorter programs have the potential to increase access and treatment capacity. Our findings demonstrate the importance of continuous and rigorous program evaluation. Limitations as well as future directions for research, such as identifying the most effective treatment components, are discussed. (PsycInfo Database Record (c) 2023 APA, all rights reserved).

25 March 2022 in Journal of Traumatic Stress
Verified
Journal Article
Open access
PHPhilip Held
Philip Held
MKMerdijana Kovacevic
Merdijana Kovacevic
KPKelsey Petrey
Kelsey Petrey
EMEnya A. Meade
Enya A. Meade
SPSarah Pridgen
Sarah Pridgen
NKNiranjan Karnik
Niranjan Karnik
Posttraumatic stress disorder (PTSD) treatments are increasingly delivered in massed formats and have shown comparable results to standard, weekly treatment. To date, massed cognitive processing therapy (CPT), delivered daily, has been delivered primarily in combination with adjunctive services and among veteran populations, but it has not been rigorously evaluated as a standalone intervention. The present study evaluated 1‐week massed CPT delivered virtually (i.e., via telehealth) to a community sample of trauma‐exposed individuals (N = 24). Using a single‐arm open‐label design, participants received CPT twice per day for 5 days. The results indicated that most participants completed treatment (n = 23, 95.8%), and no adverse events were reported. Participants exhibited large reductions in clinician‐rated, d = 2.01, and self‐reported PTSD symptoms, d = 2.55, as well as self‐reported depressive symptoms, d = 1.46. On average, participants reported a 5‐point PTSD symptom reduction and 1‐point reduction in depressive symptoms for each treatment day. Reductions in PTSD and depressive symptoms were maintained at 3‐month follow‐up. Overall, 1‐week massed CPT delivered virtually was shown to be feasible and to result in rapid symptom reductions that were sustained over time. Virtual massed CPT has the potential to increase access to effective treatments and help trauma survivors restore aspects of their lives in short amounts of time.

10 October 2024 in JMIR Research Protocols
Verified
Journal Article
Open access
PHPhilip Held
Philip Held
SPSarah A Pridgen
Sarah A Pridgen
YCYaozhong Chen
Yaozhong Chen
ZAZuhaib Akhtar
Zuhaib Akhtar
DADarpan Amin
Darpan Amin
SPSean Pohorence
Sean Pohorence
Background: Digital mental health tools, designed to augment traditional mental health treatments, are becoming increasingly important due to a wide range of barriers to accessing mental health care, including a growing shortage of clinicians. Most existing tools use rule-based algorithms, often leading to interactions that feel unnatural compared with human therapists. Large language models (LLMs) offer a solution for the development of more natural, engaging digital tools. In this paper, we detail the development of Socrates 2.0, which was designed to engage users in Socratic dialogue surrounding unrealistic or unhelpful beliefs, a core technique in cognitive behavioral therapies. The multiagent LLM-based tool features an artificial intelligence (AI) therapist, Socrates, which receives automated feedback from an AI supervisor and an AI rater. The combination of multiple agents appeared to help address common LLM issues such as looping, and it improved the overall dialogue experience. Initial user feedback from individuals with lived experiences of mental health problems as well as cognitive behavioral therapists has been positive. Moreover, tests in approximately 500 scenarios showed that Socrates 2.0 engaged in harmful responses in under 1% of cases, with the AI supervisor promptly correcting the dialogue each time. However, formal feasibility studies with potential end users are needed. Objective: This mixed methods study examines the feasibility of Socrates 2.0. Methods: On the basis of the initial data, we devised a formal feasibility study of Socrates 2.0 to gather qualitative and quantitative data about users’ and clinicians’ experience of interacting with the tool. Using a mixed method approach, the goal is to gather feasibility and acceptability data from 100 users and 50 clinicians to inform the eventual implementation of generative AI tools, such as Socrates 2.0, in mental health treatment. We designed this study to better understand how users and clinicians interact with the tool, including the frequency, length, and time of interactions, users’ satisfaction with the tool overall, quality of each dialogue and individual responses, as well as ways in which the tool should be improved before it is used in efficacy trials. Descriptive and inferential analyses will be performed on data from validated usability measures. Thematic analysis will be performed on the qualitative data. Results: Recruitment will begin in February 2024 and is expected to conclude by February 2025. As of September 25, 2024, overall, 55 participants have been recruited. Conclusions: The development of Socrates 2.0 and the outlined feasibility study are important first steps in applying generative AI to mental health treatment delivery and lay the foundation for formal feasibility studies. International Registered Report Identifier (IRRID): DERR1-10.2196/58195

18 April 2022 in Journal of Psychiatric Research
Verified
Journal Article
Open access
PHPhilip Held
Philip Held
RSRyan A. Schubert
Ryan A. Schubert
SPSarah Pridgen
Sarah Pridgen
MKMerdijana Kovacevic
Merdijana Kovacevic
MMMauricio Montes
Mauricio Montes
DSDale L. Smith
Dale L. Smith
Despite the established effectiveness of evidence-based PTSD treatments, not everyone responds the same. Specifically, some individuals respond early while others respond minimally throughout treatment. Our ability to predict these trajectories at baseline has been limited. Predicting which individuals will respond to a certain type of treatment can significantly reduce short- and long-term costs and increase the ability to preemptively match individuals with treatments to which they are most likely to respond. In the present study, we examined whether veterans' responses to a 3-week Cognitive Processing Therapy-based intensive PTSD treatment program could be accurately predicted prior to the first session. Using a sample of 432 veterans, and a wide range of demographic and clinical data collected during intake, we assessed six machine learning and statistical methods and their ability to predict fast and minimal responders prior to treatment initiation. For fast response classification, gradient boosted models (GBM) had the highest AUC-PR (0.466). For minimal response classification, elastic net (EN) had the highest mean CV AUC-PR (0.628). Using the best performing classifiers, we were able to predict both fast and minimal responders prior to starting treatment with relatively high AUC-ROC of 0.765 (GBM) and 0.826 (EN), respectively. These results may inform treatment modifications, although the accuracy may not be sufficient for clinicians to base inclusion/exclusion decisions entirely on the classifiers. Future research should evaluate whether these classifiers can be expanded to predict to which treatment type(s) an individual is most likely to respond based on various clinical, circumstantial, and biological features.

5 December 2025 in JMIR Mental Health
Verified
Journal Article
Open access
PHPhilip Held
Philip Held
SPSarah A Pridgen
Sarah A Pridgen
DSDaniel R Szoke
Daniel R Szoke
YCYaozhong Chen
Yaozhong Chen
ZAZuhaib Akhtar
Zuhaib Akhtar
DADarpan Amin
Darpan Amin
Background: Innovative, scalable mental health tools are needed to address systemic provider shortages and accessibility barriers. Large language model–based tools can provide real-time, tailored feedback to help users engage in cognitive reappraisal outside traditional therapy sessions. Socrates 2.0 (Rush University Medical Center) is a multiagent artificial intelligence tool that guides users through Socratic dialogue. Objective: The study aimed to examine the feasibility, acceptability, and potential for symptom reduction of Socrates 2.0. Methods: A total of 61 adult participants enrolled in a 4-week mixed methods preclinical feasibility study. The participants used Socrates 2.0 as desired and completed the self-report measures of depression, social anxiety, posttraumatic stress, and obsessive-compulsive symptoms at baseline and 1-month follow-up. Feasibility, acceptability, and appropriateness, along with usability and working alliance, were assessed via validated measures. The semistructured interviews explored user experiences and perceptions. Results: Participants engaged with Socrates 2.0 an average of 6.70 (SD 4.57) times over 4 weeks. Feasibility (mean 4.26, SD 0.67), acceptability (mean 4.16, SD 0.84), and usability ratings were high. Participants reported small-to-moderate reductions in depression (effect size d =0.30), social anxiety ( d =0.25), obsessive-compulsive ( d =0.33), and posttraumatic stress ( d =0.28) symptoms. Working alliance scores suggested a moderately strong perceived bond with the artificial intelligence tool. Qualitative feedback indicated that the nonjudgmental, on-demand nature of Socrates 2.0 encouraged self-reflection and exploration. Some users critiqued the repeated questioning style and limited conversation depth. Conclusions: Socrates 2.0 was perceived as feasible, acceptable, and moderately helpful for self-guided cognitive reappraisal, demonstrating potential as an adjunct to traditional therapy. Further research, including randomized trials, is needed to determine effectiveness across different populations, optimize personalization, and address the repetitive conversational nature.

26 August 2021 in Psychological Trauma: Theory, Research, Practice, and Policy
Verified
Journal Article
Closed access
PHPhilip Held
Philip Held
JCJennifer A. Coleman
Jennifer A. Coleman
KPKelsey Petrey
Kelsey Petrey
BKBrian J. Klassen
Brian J. Klassen
SPSarah Pridgen
Sarah Pridgen
RHRebecca Van Horn
Rebecca Van Horn
Evidence-based treatments for posttraumatic stress disorder (PTSD) can be effectively delivered over telehealth. There are, however, no studies that examine the effectiveness of delivering evidence-based treatments for PTSD in an intensive format via telehealth. Telehealth may be well-suited as a delivery modality because it may address barriers specific to intensive treatments. To address this gap, we report on a case series of ten consecutively enrolled veterans (60% male; mean age 42.3, SD = 6.3) who participated in a virtual 2-week, Cognitive Processing Therapy (CPT)-based intensive program. All (100%) participants completed treatment and reported large reductions in PTSD and depression symptoms pre- to post-treatment (Hedge’s gws = 2.83 and gws = 1.97, respectively), pre- to 3-month follow-up (Hedge’s gws = 0.99 and gws = 1.24, respectively), as well as very high satisfaction. Results of this case series suggest that evidence-based treatments for PTSD can be effectively delivered in intensive formats over telehealth and lay the foundation for more rigorously designed and larger scale research comparing virtual to in-person delivered intensive PTSD treatments.